Published in Int J Mol Sci on July 24, 2013
Association between diabetes and amyotrophic lateral sclerosis in Sweden. Eur J Neurol (2015) 2.84
ALS as a distal axonopathy: molecular mechanisms affecting neuromuscular junction stability in the presymptomatic stages of the disease. Front Neurosci (2014) 1.10
The neurodegenerative effects of selenium are inhibited by FOXO and PINK1/PTEN regulation of insulin/insulin-like growth factor signaling in Caenorhabditis elegans. Neurotoxicology (2014) 0.82
Evaluating a Gene-Environment Interaction in Amyotrophic Lateral Sclerosis: Methylmercury Exposure and Mutated SOD1. Curr Environ Health Rep (2017) 0.78
Amyotrophic lateral sclerosis and environmental factors. Funct Neurol (2016) 0.77
No association between biopsy-verified celiac disease and subsequent amyotrophic lateral sclerosis--a population-based cohort study. Eur J Neurol (2014) 0.77
Trends in motor neuron disease: association with latitude and air lead levels in Spain. Neurol Sci (2016) 0.75
Preventive effects of imperatorin on perfluorohexanesulfonate-induced neuronal apoptosis via inhibition of intracellular calcium-mediated ERK pathway. Korean J Physiol Pharmacol (2016) 0.75
The interaction of genetics and environmental toxicants in amyotrophic lateral sclerosis: results from animal models. Neural Regen Res (2017) 0.75
Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature (1993) 21.65
Amyotrophic lateral sclerosis. Lancet (2011) 5.86
The neurobiology of zinc in health and disease. Nat Rev Neurosci (2005) 5.07
Editing-defective tRNA synthetase causes protein misfolding and neurodegeneration. Nature (2006) 5.07
The less harmful cigarette: a controversial issue. a tribute to Ernst L. Wynder. Chem Res Toxicol (2001) 3.59
Excess incidence of ALS in young Gulf War veterans. Neurology (2003) 2.75
Misfolded CuZnSOD and amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A (2003) 2.65
Paraoxonase cluster polymorphisms are associated with sporadic ALS. Neurology (2006) 2.38
Decreased metallation and activity in subsets of mutant superoxide dismutases associated with familial amyotrophic lateral sclerosis. J Biol Chem (2002) 2.34
Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease. Lancet Neurol (2011) 2.34
Biomagnification of cycad neurotoxins in flying foxes: implications for ALS-PDC in Guam. Neurology (2003) 2.27
Biomagnification of cyanobacterial neurotoxins and neurodegenerative disease among the Chamorro people of Guam. Proc Natl Acad Sci U S A (2003) 2.20
Induction of nitric oxide-dependent apoptosis in motor neurons by zinc-deficient superoxide dismutase. Science (1999) 2.17
Molecular and ionic mimicry and the transport of toxic metals. Toxicol Appl Pharmacol (2005) 1.97
Neurodegenerative diseases in welders and other workers exposed to high levels of magnetic fields. Epidemiology (2003) 1.82
Cyanobacterial neurotoxin BMAA in ALS and Alzheimer's disease. Acta Neurol Scand (2009) 1.75
Influence of prenatal lead exposure on genomic methylation of cord blood DNA. Environ Health Perspect (2009) 1.74
Occupational exposures and amyotrophic lateral sclerosis. A population-based case-control study. Am J Epidemiol (1997) 1.73
Mortality in chemical workers potentially exposed to 2,4-dichlorophenoxyacetic acid (2,4-D) 1945-94: an update. Occup Environ Med (2001) 1.70
Quantitative magnetic resonance brain imaging in US army veterans of the 1991 Gulf War potentially exposed to sarin and cyclosarin. Neurotoxicology (2007) 1.68
A mechanism for slow release of biomagnified cyanobacterial neurotoxins and neurodegenerative disease in Guam. Proc Natl Acad Sci U S A (2004) 1.67
The association of exposure to lead, mercury, and selenium and the development of amyotrophic lateral sclerosis and the epigenetic implications. Neurodegener Dis (2010) 1.63
Endemic selenium intoxication of humans in China. Am J Clin Nutr (1983) 1.61
Pesticides. Pediatrics (2004) 1.60
Paraoxonase gene polymorphisms and sporadic ALS. Neurology (2006) 1.56
Spatial clustering of amyotrophic lateral sclerosis in Finland at place of birth and place of death. Am J Epidemiol (2003) 1.54
Motor neurone disease and exposure to lead. J Neurol Neurosurg Psychiatry (1970) 1.52
A case-control study of amyotrophic lateral sclerosis. Am J Epidemiol (1986) 1.49
Polychlorinated biphenyls and neurodegenerative disease mortality in an occupational cohort. Epidemiology (2006) 1.46
Pathogenic superoxide dismutase structure, folding, aggregation and turnover. Curr Opin Chem Biol (2006) 1.44
ALS and mercury intoxication: a relationship? Clin Neurol Neurosurg (2007) 1.42
Prospective study of chemical exposures and amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry (2009) 1.38
Neurotoxic flying foxes as dietary items for the Chamorro people, Marianas Islands. J Ethnopharmacol (2006) 1.38
Cyanobacterial Blooms and the Occurrence of the neurotoxin beta-N-methylamino-L-alanine (BMAA) in South Florida Aquatic Food Webs. Harmful Algae (2010) 1.36
Abnormal tissue distribution of lead in amyotrophic lateral sclerosis. J Neurol Sci (1976) 1.31
Transfer of a cyanobacterial neurotoxin within a temperate aquatic ecosystem suggests pathways for human exposure. Proc Natl Acad Sci U S A (2010) 1.30
Amyotrophic lateral sclerosis in a high selenium environment. JAMA (1977) 1.29
Association of low PON1 type Q (type A) arylesterase activity with neurologic symptom complexes in Gulf War veterans. Toxicol Appl Pharmacol (1999) 1.28
Molecular neuropathology of TDP-43 proteinopathies. Int J Mol Sci (2009) 1.26
Risk factors for motor neuron disease: a case-control study based on patients from the Scottish Motor Neuron Disease Register. J Neurol Neurosurg Psychiatry (1993) 1.25
The role of environmental mercury, lead and pesticide exposure in development of amyotrophic lateral sclerosis. Neurotoxicology (2009) 1.24
Rethinking the excitotoxic ionic milieu: the emerging role of Zn(2+) in ischemic neuronal injury. Curr Mol Med (2004) 1.23
Organophosphate-induced brain damage: mechanisms, neuropsychiatric and neurological consequences, and potential therapeutic strategies. Neurotoxicology (2012) 1.23
Smoking and risk of amyotrophic lateral sclerosis: a pooled analysis of 5 prospective cohorts. Arch Neurol (2011) 1.23
Smoking and the risk of amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry (2010) 1.22
Paraoxonase 1 (PON1) status and substrate hydrolysis. Toxicol Appl Pharmacol (2008) 1.21
Adverse health effects of selenium in humans. Rev Environ Health (2002) 1.21
Paraoxonase gene mutations in amyotrophic lateral sclerosis. Ann Neurol (2010) 1.20
Amyotrophic lateral sclerosis and parkinsonism-dementia complex of Guam: changing incidence rates during the past 60 years. Am J Epidemiol (2003) 1.17
Production of the neurotoxin BMAA by a marine cyanobacterium. Mar Drugs (2007) 1.15
Pesticide exposure and amyotrophic lateral sclerosis. Neurotoxicology (2012) 1.15
Amyloid-like aggregates of neuronal tau induced by formaldehyde promote apoptosis of neuronal cells. BMC Neurosci (2007) 1.14
Amyotrophic lateral sclerosis. Curr Opin Neurol (2012) 1.13
A case-control study of motor neurone disease: its relation to heritability, and occupational exposures, particularly to solvents. Br J Ind Med (1992) 1.13
Amyotrophic lateral sclerosis as a complex genetic disease. Biochim Biophys Acta (2006) 1.13
Two sites in the MAPT region confer genetic risk for Guam ALS/PDC and dementia. Hum Mol Genet (2006) 1.13
Lead exposure as a risk factor for amyotrophic lateral sclerosis. Neurodegener Dis (2005) 1.13
Inorganic mercury intoxication reminiscent of amyotrophic lateral sclerosis. J Occup Med (1978) 1.12
Mercury intoxication simulating amyotrophic lateral sclerosis. JAMA (1983) 1.11
Inhibition of sleep in rats by inorganic selenium compounds, inhibitors of prostaglandin D synthase. Proc Natl Acad Sci U S A (1991) 1.10
Smoking, alcohol consumption, and the risk of amyotrophic lateral sclerosis: a population-based study. Am J Epidemiol (2012) 1.10
The copper chelator d-penicillamine delays onset of disease and extends survival in a transgenic mouse model of familial amyotrophic lateral sclerosis. Eur J Neurosci (1997) 1.09
Exposure to chemicals and metals and risk of amyotrophic lateral sclerosis: a systematic review. Amyotroph Lateral Scler (2009) 1.08
Analysis of factors that modify susceptibility and rate of progression in amyotrophic lateral sclerosis (ALS). Amyotroph Lateral Scler (2006) 1.08
Paraoxonase promoter and intronic variants modify risk of sporadic amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry (2007) 1.07
Beta-N-methylamino-L-alanine (BMAA) in novel South African cyanobacterial isolates. Ecotoxicol Environ Saf (2008) 1.07
Smoking, snuff dipping and the risk of amyotrophic lateral sclerosis--a prospective cohort study. Neuroepidemiology (2006) 1.06
Exposure to electromagnetic fields and risk of central nervous system disease in utility workers. Epidemiology (2000) 1.06
Antecedent events in motor neuron disease. J Neurol Neurosurg Psychiatry (1983) 1.05
Amyotrophic lateral sclerosis and exposure to environmental toxins: an Australian case-control study. Neuroepidemiology (2006) 1.05
Genetic susceptibility to environmental toxicants in ALS. Am J Med Genet B Neuropsychiatr Genet (2007) 1.05
Cyanobacteria and BMAA exposure from desert dust: a possible link to sporadic ALS among Gulf War veterans. Amyotroph Lateral Scler (2009) 1.04
The transition metals copper and iron in neurodegenerative diseases. Chem Biol Interact (2010) 1.04
Blood lead levels and risk factors for lead poisoning among children in a Mexican smelting community. Arch Environ Health (2003) 1.03
Amyotrophic lateral sclerosis, lead, and genetic susceptibility: polymorphisms in the delta-aminolevulinic acid dehydratase and vitamin D receptor genes. Environ Health Perspect (2003) 1.03
Vitamin E against oxidative damage caused by formaldehyde in frontal cortex and hippocampus: biochemical and histological studies. J Chem Neuroanat (2005) 1.03
A common haplotype within the PON1 promoter region is associated with sporadic ALS. Amyotroph Lateral Scler (2008) 1.02
A cluster of amyotrophic lateral sclerosis in New Hampshire: a possible role for toxic cyanobacteria blooms. Amyotroph Lateral Scler (2009) 1.02
Amyotrophic lateral sclerosis. A case-control study following detection of a cluster in a small Wisconsin community. Arch Neurol (1990) 1.01
A case of amyotrophic lateral sclerosis in electronic parts manufacturing worker exposed to lead. Neurotoxicology (2006) 1.01
Is exposure to cyanobacteria an environmental risk factor for amyotrophic lateral sclerosis and other neurodegenerative diseases? Amyotroph Lateral Scler Frontotemporal Degener (2013) 1.01
Association between blood lead and the risk of amyotrophic lateral sclerosis. Am J Epidemiol (2010) 1.00
A case-control study of amyotrophic lateral sclerosis. Neuroepidemiology (1991) 1.00
Amyotrophic lateral sclerosis among 1991 Gulf War veterans: evidence for a time-limited outbreak. Neuroepidemiology (2008) 0.99
Paraoxonase 1 (PON1) as a genetic determinant of susceptibility to organophosphate toxicity. Toxicology (2012) 0.99
Association of lead exposure with survival in amyotrophic lateral sclerosis. Environ Health Perspect (2008) 0.98
Polymorphisms in metabolic genes, their combination and interaction with tobacco smoke and alcohol consumption and risk of gastric cancer: a case-control study in an Italian population. BMC Cancer (2007) 0.98
Early hippocampal cell death, and late learning and memory deficits in rats exposed to the environmental toxin BMAA (β-N-methylamino-L-alanine) during the neonatal period. Behav Brain Res (2011) 0.98
Motor neuron disease in the province of Ferrara, Italy, in 1964-1982. Neurology (1988) 0.97
Amyotrophic lateral sclerosis and occupational heavy metal exposure: a case-control study. Neuroepidemiology (1986) 0.97
Detection of the neurotoxin BMAA within cyanobacteria isolated from freshwater in China. Toxicon (2009) 0.96
Interaction between genes and environment in neurodegenerative diseases. C R Biol (2007) 0.96
Epigenetics in neurodegeneration: a new layer of complexity. Prog Neuropsychopharmacol Biol Psychiatry (2010) 0.96
Content of the neurotoxins cycasin (methylazoxymethanol beta-D-glucoside) and BMAA (beta-N-methylamino-L-alanine) in cycad flour prepared by Guam Chamorros. Neurology (1992) 0.96
Mapping of gene expression reveals CYP27A1 as a susceptibility gene for sporadic ALS. PLoS One (2012) 0.95
Risk and protective factors for sporadic Alzheimer's disease. Acta Virol (2007) 0.94
Paraoxonase 1 (PON1) organophosphate hydrolysis is not reduced in ALS. Neurology (2008) 0.94
N-acetyl-L-cysteine improves survival and preserves motor performance in an animal model of familial amyotrophic lateral sclerosis. Neuroreport (2000) 0.94
Low paraoxonase in Persian Gulf War Veterans self-reporting Gulf War Syndrome. Biochem Biophys Res Commun (2000) 0.93
Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron (2010) 7.87
Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease. Neurology (2012) 2.63
Independent component analysis of fMRI group studies by self-organizing clustering. Neuroimage (2005) 2.33
Further evidence that SPG3A gene mutations cause autosomal dominant hereditary spastic paraplegia. Ann Neurol (2002) 2.07
Independent component model of the default-mode brain function: Assessing the impact of active thinking. Brain Res Bull (2006) 1.99
A two-stage genome-wide association study of sporadic amyotrophic lateral sclerosis. Hum Mol Genet (2009) 1.93
Visual resting-state network in relapsing-remitting MS with and without previous optic neuritis. Neurology (2012) 1.89
Differential sex-independent amygdala response to infant crying and laughing in parents versus nonparents. Biol Psychiatry (2003) 1.74
Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72. Brain (2012) 1.67
Two Italian kindreds with familial amyotrophic lateral sclerosis due to FUS mutation. Neurobiol Aging (2009) 1.62
Spatiotemporal pattern of neural processing in the human auditory cortex. Science (2002) 1.48
Pain processing in patients with migraine: an event-related fMRI study during trigeminal nociceptive stimulation. J Neurol (2012) 1.43
FUS mutations in sporadic amyotrophic lateral sclerosis. Neurobiol Aging (2010) 1.42
Executive resting-state network connectivity in migraine without aura. Cephalalgia (2012) 1.29
Rhythm-specific modulation of the sensorimotor network in drug-naive patients with Parkinson's disease by levodopa. Brain (2013) 1.29
Spatial independent component analysis of functional MRI time-series: to what extent do results depend on the algorithm used? Hum Brain Mapp (2002) 1.27
Independent component model of the default-mode brain function: combining individual-level and population-level analyses in resting-state fMRI. Magn Reson Imaging (2008) 1.25
Resting-state brain connectivity in patients with Parkinson's disease and freezing of gait. Parkinsonism Relat Disord (2012) 1.20
C9ORF72 hexanucleotide repeat expansions in the Italian sporadic ALS population. Neurobiol Aging (2012) 1.13
Gender-related effect of clinical and genetic variables on the cognitive impairment in multiple sclerosis. J Neurol (2004) 1.10
Restless legs syndrome and primary headaches: a clinical study. Neurol Sci (2008) 1.09
Atorvastatin combined to interferon to verify the efficacy (ACTIVE) in relapsing-remitting active multiple sclerosis patients: a longitudinal controlled trial of combination therapy. Mult Scler (2010) 1.09
Real-time independent component analysis of fMRI time-series. Neuroimage (2003) 1.07
Could mitochondrial haplogroups play a role in sporadic amyotrophic lateral sclerosis? Neurosci Lett (2004) 1.04
Disrupted default mode network connectivity in migraine without aura. J Headache Pain (2013) 1.02
Distributed changes in default-mode resting-state connectivity in multiple sclerosis. Mult Scler (2011) 1.02
Proton MR spectroscopy of cerebral gliomas at 3 T: spatial heterogeneity, and tumour grade and extent. Eur Radiol (2008) 0.99
Vacuolating megalencephalic leukoencephalopathy with subcortical cysts: functional studies of novel variants in MLC1. Hum Mutat (2006) 0.98
Interaction between aging and neurodegeneration in amyotrophic lateral sclerosis. Neurobiol Aging (2010) 0.96
Sporadic ALS is not associated with VAPB gene mutations in Southern Italy. J Negat Results Biomed (2006) 0.94
Interictal cortical reorganization in episodic migraine without aura: an event-related fMRI study during parametric trigeminal nociceptive stimulation. Neurol Sci (2011) 0.93
Hirayama disease: three cases assessed by F wave, somatosensory and motor evoked potentials and magnetic resonance imaging not supporting flexion myelopathy. Neurol Sci (2008) 0.93
Pattern and significance of white matter abnormalities in myotonic dystrophy type 1: an MRI study. J Neurol (2002) 0.92
Recurrent glioblastoma multiforme versus radiation injury: a multiparametric 3-T MR approach. Radiol Med (2014) 0.90
Alcohol increases spontaneous BOLD signal fluctuations in the visual network. Neuroimage (2010) 0.90
Mutational analysis of 206 families with cavernous malformations. J Neurosurg (2003) 0.89
The role of emergency neurology in Italy: outcome of a consensus meeting for a Intersociety position. Neurol Sci (2011) 0.89
Resting state cortical electroencephalographic rhythms are related to gray matter volume in subjects with mild cognitive impairment and Alzheimer's disease. Hum Brain Mapp (2012) 0.88
Resting-state functional connectivity associated with mild cognitive impairment in Parkinson's disease. J Neurol (2014) 0.87
Brain MRI features of congenital- and adult-form myotonic dystrophy type 1: case-control study. Neuromuscul Disord (2002) 0.87
Diffuse neuroaxonal involvement in mucolipidosis IV as assessed by proton magnetic resonance spectroscopic imaging. J Child Neurol (2003) 0.87
Distributed analysis of simultaneous EEG-fMRI time-series: modeling and interpretation issues. Magn Reson Imaging (2009) 0.85
Decreased concentration of adiponectin together with a selective reduction of its high molecular weight oligomers is involved in metabolic complications of myotonic dystrophy type 1. Eur J Endocrinol (2011) 0.85
Functional correlates of cognitive dysfunction in multiple sclerosis: A multicenter fMRI Study. Hum Brain Mapp (2014) 0.84
Widespread structural and functional connectivity changes in amyotrophic lateral sclerosis: insights from advanced neuroimaging research. Neural Plast (2012) 0.83
Natalizumab: a country-based surveillance program. Neurol Sci (2008) 0.82
Accuracy of death certificates for amyotrophic lateral sclerosis varies significantly from north to south of Italy: implications for mortality studies. Neuroepidemiology (2004) 0.82
Clinical and cognitive correlations of regional gray matter atrophy in progressive supranuclear palsy. Parkinsonism Relat Disord (2013) 0.82
Resting state cortical electroencephalographic rhythms and white matter vascular lesions in subjects with Alzheimer's disease: an Italian multicenter study. J Alzheimers Dis (2011) 0.81
The Contribution of Resting State Networks to the Study of Cortical Reorganization in MS. Mult Scler Int (2013) 0.81
FUS mutations in sporadic amyotrophic lateral sclerosis: clinical and genetic analysis. Neurobiol Aging (2011) 0.81
Familial aggregation of white matter lesions in myotonic dystrophy type 1. Neuromuscul Disord (2008) 0.81
Motor and extramotor neurodegeneration in amyotrophic lateral sclerosis: a 3T high angular resolution diffusion imaging (HARDI) study. Amyotroph Lateral Scler Frontotemporal Degener (2013) 0.81
Cortical sources of resting state electroencephalographic alpha rhythms deteriorate across time in subjects with amnesic mild cognitive impairment. Neurobiol Aging (2013) 0.81
How does spatial extent of fMRI datasets affect independent component analysis decomposition? Hum Brain Mapp (2006) 0.81
Distributed corpus callosum involvement in amyotrophic lateral sclerosis: a deterministic tractography study using q-ball imaging. J Neurol (2013) 0.80
Morphostructural MRI abnormalities related to neuropsychiatric disorders associated to multiple sclerosis. Mult Scler Int (2013) 0.79
Further evidence that D90A-SOD1 mutation is recessively inherited in ALS patients in Italy. Amyotroph Lateral Scler (2009) 0.79
An MRI digital brain phantom for validation of segmentation methods. Med Image Anal (2011) 0.79
A transient third cranial nerve palsy as presenting sign of spontaneous intracranial hypotension. J Headache Pain (2011) 0.79
Transcutaneous supraorbital neurostimulation in "de novo" patients with migraine without aura: the first Italian experience. J Headache Pain (2015) 0.79
Amyotrophic lateral sclerosis and multiple sclerosis overlap: a case report. Case Rep Med (2012) 0.79
Cortical sources of resting state EEG rhythms are sensitive to the progression of early stage Alzheimer's disease. J Alzheimers Dis (2013) 0.79
Guidelines from The Italian Neurological and Neuroradiological Societies for the use of magnetic resonance imaging in daily life clinical practice of multiple sclerosis patients. Neurol Sci (2013) 0.79
Impaired transmethylation potential in Parkinson's disease patients treated with L-Dopa. Neurosci Lett (2009) 0.78
Dysfunctions within limbic-motor networks in amyotrophic lateral sclerosis. Neurobiol Aging (2013) 0.78
Familial clustering in Italian progressive-onset and bout-onset multiple sclerosis. Neurol Sci (2014) 0.77
Infratentorial progressive multifocal leukoencephalopathy in a patient treated with fludarabine and rituximab. Neurol Sci (2008) 0.77
The pain in migraine beyond the pain of migraine. Neurol Sci (2012) 0.77
Migraine and trigeminal system-I can feel it coming…. Curr Pain Headache Rep (2013) 0.76
Clinical features and lifestyle of patients with amyotrophic lateral sclerosis in Campania: brief overview of an Italian database. Ann Ist Super Sanita (2012) 0.76
Hemiparkinsonism and hemiatrophy syndrome: a rare observation. Clin Neurol Neurosurg (2010) 0.76
Apolipoprotein E genotype does not influence the progression of multiple sclerosis. J Neurol (2003) 0.76
Lack of association between estrogen receptor 1 gene polymorphisms and multiple sclerosis in southern Italy in humans. Neurosci Lett (2002) 0.76
Paternally inherited case of congenital DM1: brain MRI and review of literature. Brain Dev (2008) 0.76
Livedo and ischemic strokes: diagnostic hints of a rare condition. Neurol Sci (2013) 0.76
Earliest videofluoromanometric pharyngeal signs of dysphagia in ALS patients. Dysphagia (2014) 0.76
Spinal pseudoathetosis: an unusual presentation of cervical spondylotic myelopathy. Neurol Sci (2013) 0.75
Clinical reasoning: a 62-year-old man with right wrist drop. Neurology (2013) 0.75
Problem in diagnostic radiology. Clin Anat (2008) 0.75